Avicenna Biosciences, Inc. — Form D/A
Avicenna Biosciences, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2023-03-22. The offering totals $41K, of which $27K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-22
- Form: D/A
- Accession: 0001824034-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41K
- Amount sold: $27K
- Remaining: $14K
- Investors: 1
- Date of first sale: 2022-02-17
- Revenue range: Decline to Disclose
- SEC file number: 021-463082
Issuer
- Name: Avicenna Biosciences, Inc.
- CIK: 0001824034
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 101 W. CHAPEL HILL STREET, SUITE 210, DURHAM, NC, 27701
- Phone: 919-667-2504
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Pieter Burger | Director | Durham, NC |
| Pieter Burger | Executive Officer | Durham, NC |
| John Hamer | Director | Durham, NC |
| Dennis Langer | Director | Naples, FL |
| Thomas Kaiser | Director | Durham, NC |
| Thomas Kaiser | Executive Officer | Durham, NC |
| Christopher Meldrum | Director | Durham, NC |
| Christopher Meldrum | Executive Officer | Durham, NC |
Other filings by this issuer (6)
More